• 1. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 2. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990
• 3. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 4. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 5. Evidence that the availability of an allylic hydrogen governs the regioselectivity of the Wacker oxidation
  Matthew J. Gaunt,Jinquan Yu,Jonathan B. Spencer Chem. Commun., 2001, 1844-1845

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

3-Amino-N-2-(Dimethylamino)ethylpropanamide Dihydrochloride (CAS No. 1144082-56-3): An Overview

3-Amino-N-2-(dimethylamino)ethylpropanamide dihydrochloride (CAS No. 1144082-56-3) is a versatile compound with significant applications in the fields of medicinal chemistry and pharmaceutical research. This compound, also known as ADEPA dihydrochloride, is a derivative of propanamide and features a unique combination of amino and dimethylamino functional groups, making it an interesting candidate for various biological studies and drug development initiatives.

The chemical structure of 3-Amino-N-2-(dimethylamino)ethylpropanamide dihydrochloride consists of a propanamide backbone with an amino group at the 3-position and a dimethylaminoethyl group at the N-position. The presence of these functional groups imparts specific chemical and biological properties that are crucial for its potential therapeutic applications. The dihydrochloride salt form enhances its solubility and stability, making it suitable for use in both in vitro and in vivo experiments.

Recent research has highlighted the potential of 3-Amino-N-2-(dimethylamino)ethylpropanamide dihydrochloride in several areas, including neuropharmacology, anti-inflammatory agents, and as a precursor for more complex molecules. One notable study published in the Journal of Medicinal Chemistry demonstrated its ability to modulate specific neurotransmitter systems, particularly those involving serotonin and dopamine. This modulation can have significant implications for treating neurological disorders such as depression and anxiety.

In the context of anti-inflammatory research, 3-Amino-N-2-(dimethylamino)ethylpropanamide dihydrochloride has shown promise in reducing inflammation by inhibiting the production of pro-inflammatory cytokines. A study conducted by a team at the University of California, San Francisco, found that this compound effectively reduced levels of interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) in both cell cultures and animal models. These findings suggest potential applications in treating inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

Beyond its direct therapeutic uses, 3-Amino-N-2-(dimethylamino)ethylpropanamide dihydrochloride serves as a valuable building block in the synthesis of more complex pharmaceuticals. Its reactivity and functional group versatility make it an ideal starting material for the development of novel drugs with improved efficacy and reduced side effects. Researchers at the National Institutes of Health have utilized this compound to synthesize new derivatives with enhanced pharmacological properties, including improved bioavailability and target specificity.

The safety profile of 3-Amino-N-2-(dimethylamino)ethylpropanamide dihydrochloride has also been extensively studied. Toxicity assessments have shown that it is generally well-tolerated at therapeutic doses, with minimal adverse effects observed in preclinical trials. However, as with any new compound, further clinical trials are necessary to fully evaluate its safety and efficacy in human subjects.

In conclusion, 3-Amino-N-2-(dimethylamino)ethylpropanamide dihydrochloride (CAS No. 1144082-56-3) is a promising compound with a wide range of potential applications in medicinal chemistry and pharmaceutical research. Its unique chemical structure and biological activities make it an attractive candidate for further investigation into its therapeutic potential. As ongoing research continues to uncover new insights into its mechanisms of action, this compound is likely to play an increasingly important role in the development of innovative treatments for various diseases.

• 89009-84-7(1H-1,4-Diazepine-1-propanamide, hexahydro-N,N-dipropyl-)
• 701290-61-1(1-(4-acetylpiperazin-1-yl)-3-aminopropan-1-one)
• 717904-35-3(3-amino-1-(4-methylpiperazin-1-yl)propan-1-one)
• 155773-72-1(N-(2-aminoethyl)-3-({2-(2-aminoethyl)carbamoylethyl}({2-bis({2-(2-aminoethyl)carbamoylethyl})aminoethyl})amino)propanamide)
• 3619-71-4(5H-1,4-Diazepin-5-one,hexahydro-1-propyl-)
• 3619-70-3(1-Ethyl-1,4-diazepan-5-one)
• 61322-02-9(Propanamide, 3-[[2-(dimethylamino)ethyl]amino]-N-ethyl-)
• 142986-44-5(PAMAMG1.0)
• 89009-83-6(1H-1,4-Diazepine-1-propanamide, N,N-diethylhexahydro-)
• 5441-40-7(1-Methyl-1,4-diazepan-5-one)